» Articles » PMID: 27708473

Zika: the Origin and Spread of a Mosquito-borne Virus

Overview
Specialty Public Health
Date 2016 Oct 7
PMID 27708473
Citations 207
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the temporal and geographical distribution of Zika virus infection and associated neurological disorders, from 1947 to 1 February 2016, when Zika became a Public Health Emergency of International Concern (PHEIC).

Methods: We did a literature search using the terms "Zika" and "ZIKV" in PubMed, cross-checked the findings for completeness against other published reviews and added formal notifications to WHO submitted under the International Health Regulations.

Findings: From the discovery of Zika virus in Uganda in 1947 to the declaration of a PHEIC by the World Health Organization (WHO) on 1 February 2016, a total of 74 countries and territories had reported human Zika virus infections. The timeline in this paper charts the discovery of the virus (1947), its isolation from mosquitos (1948), the first human infection (1952), the initial spread of infection from Asia to a Pacific island (2007), the first known instance of sexual transmission (2008), reports of Guillain-Barré syndrome (2014) and microcephaly (2015) linked to Zika infections and the first appearance of Zika in the Americas (from 2015).

Conclusion: Zika virus infection in humans appears to have changed in character as its geographical range has expanded from equatorial Africa and Asia. The change is from an endemic, mosquito-borne infection causing mild illness to one that can cause large outbreaks linked with neurological sequelae and congenital abnormalities.

Citing Articles

Polygenic viral factors enable efficient mosquito-borne transmission of African Zika virus.

Torii S, Lord J, Lavina M, Prot M, Lecuyer A, Diagne C bioRxiv. 2025; .

PMID: 39896559 PMC: 11785240. DOI: 10.1101/2025.01.23.634482.


RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?.

Stegeman S, Kourko O, Amsden H, Pellizzari Delano I, Mamatis J, Roth M J Innate Immun. 2025; 17(1):126-153.

PMID: 39820070 PMC: 11845175. DOI: 10.1159/000543608.


Microcephaly protein ANKLE2 promotes Zika virus replication.

Fishburn A, Florio C, Klaessens T, Prince B, Adia N, Lopez N mBio. 2025; 16(2):e0268324.

PMID: 39804047 PMC: 11796389. DOI: 10.1128/mbio.02683-24.


An Overview of Zika Virus and Zika Virus Induced Neuropathies.

Wahaab A, Mustafa B, Hameed M, Batool H, Tran Nguyen Minh H, Tawaab A Int J Mol Sci. 2025; 26(1.

PMID: 39795906 PMC: 11719530. DOI: 10.3390/ijms26010047.


The Implementation of the International Health Regulations on Vector-Borne Diseases: A Scoping Review of the Qualitative Evidence Performed Worldwide.

Alho A, Quelhas C, Subtil I, Adrego T, Durao J Port J Public Health. 2024; 41(3):218-229.

PMID: 39469617 PMC: 11320639. DOI: 10.1159/000531752.


References
1.
HAMMON W, SCHRACK Jr W, SATHER G . Serological survey for a arthropod-borne virus infections in the Philippines. Am J Trop Med Hyg. 1958; 7(3):323-8. DOI: 10.4269/ajtmh.1958.7.323. View

2.
Monlun E, Zeller H, Le Guenno B, Traore-Lamizana M, Hervy J, Adam F . [Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal]. Bull Soc Pathol Exot. 1993; 86(1):21-8. View

3.
Enserink M . INFECTIOUS DISEASES. An obscure mosquito-borne disease goes global. Science. 2015; 350(6264):1012-3. DOI: 10.1126/science.350.6264.1012. View

4.
DICK G, KITCHEN S, HADDOW A . Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5):509-20. DOI: 10.1016/0035-9203(52)90042-4. View

5.
Macnamara F, Horn D, PORTERFIELD J . Yellow fever and other arthropod-borne viruses; a consideration of two serological surveys made in South Western Nigeria. Trans R Soc Trop Med Hyg. 1959; 53(2):202-12. DOI: 10.1016/0035-9203(59)90072-0. View